Jeff Fairman - Dec 9, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Dec 9, 2021
Transactions value $
-$2,713
Form type
4
Date filed
12/13/2021, 04:20 PM
Previous filing
Oct 28, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $234 +131 +2.13% $1.79* 6.29K Dec 9, 2021 Direct F1
transaction PCVX Common Stock Sale -$2.95K -131 -2.08% $22.50 6.16K Dec 9, 2021 Direct F2
holding PCVX Common Stock 341K Dec 9, 2021 By Fairman Family Trust
holding PCVX Common Stock 50K Dec 9, 2021 By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -131 -0.21% $0.00 62.7K Dec 9, 2021 Common Stock 131 $1.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,016 shares acquired under the Employee Stock Purchase Plan on November 17, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The shares subject to the option are fully vested and exercisable.